• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Clovis Oncology, Inc. (CLVS)

    -NasdaqGS
    73.44 Up 1.23(1.70%) Mar 27, 4:00PM EDT
    |After Hours : 73.44 0.00 (0.00%) Mar 27, 4:33PM EDT
    Add to Portfolio
    Prev Close:72.21
    Open:72.34
    Bid:73.44 x 600
    Ask:74.89 x 100
    1y Target Est:91.11
    Beta:1.51
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:71.52 - 74.28
    52wk Range:35.33 - 83.46
    Volume:326,150
    Avg Vol (3m):517,411
    Market Cap:2.50B
    P/E (ttm):N/A
    EPS (ttm):-4.72
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CLVS

    Comparison

    Symbol% ChgMkt Cap
    CLVSUp 1.70%2.50B
    IMMU 0.00%346.47M
    LRUSF 0.00%N/A
    THLDUp 3.69%290.08M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):180.30
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-8.11
    Quarterly EPS Est (Mar-15) :-1.82
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback